Published in Ann Burns Fire Disasters on March 31, 2013
Is a self-inflicted burn part of a repeated self-harm pattern? Ann Burns Fire Disasters (2015) 0.75
The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev (2010) 7.09
Chromium. J Toxicol Clin Toxicol (1999) 1.64
Pathophysiology of accidental hypothermia. QJM (2002) 1.54
Acute potassium dichromate poisoning. Treated by peritoneal dialysis. Am J Dis Child (1970) 1.44
Intravascular haemolysis and acute renal failure following potassium dichromate poisoning. Postgrad Med J (1978) 1.01
Hypothermia with indoor occurrence is associated with a worse outcome. Intensive Care Med (2000) 1.00
Specificity and treatment of thermal and inhalation injury following an explosion in a cement manufacturing kiln. Burns (1993) 0.94
Clinical characteristics of seven patients with Aeromonas septicemia in a Japanese hospital. Tohoku J Exp Med (2011) 0.90
Failure of dialysis therapy in potassium dichromate poisoning. J Emerg Med (1983) 0.89
Cement burns: a review 1960-2000. Contact Dermatitis (2001) 0.88
SEVERE REACTION TO CEMENT. Arch Environ Health (1963) 0.87
Subacute fatal aluminum poisoning in dialyzed patients: post-mortem toxicological findings. Forensic Sci Int (2002) 0.85
Cement burns and their treatment. Burns (1992) 0.84
Successful treatment of a patient suffering from severe acute potassium dichromate poisoning with liver transplantation. Transplantation (2000) 0.81
Acute renal failure after chromic acid injection. West J Med (1986) 0.80
Classification and specificity of cement burns. Burns (1995) 0.79
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation. J Exp Med (1975) 7.87
Binding of sheep red blood cells to a large population of human lymphocytes. Nature (1971) 7.67
Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood (1973) 4.99
Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med (1981) 3.93
Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G. J Exp Med (1975) 3.80
Theta-bearing and complement-receptor lymphocytes are distinct populations of cells. Science (1971) 3.16
Mechanism of binding of soluble immune complexes to lymphocytes. Cell Immunol (1973) 2.93
Studies on the selective lysis and purification of Trypanosoma cruzi. J Exp Med (1975) 2.54
Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med (1972) 2.50
The induction of macrophage spreading: role of coagulation factors and the complement system. J Exp Med (1976) 2.41
Prospective multicenter study on CA 125 in postmenopausal pelvic masses. Gynecol Oncol (1994) 2.38
Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. Proc Natl Acad Sci U S A (1970) 2.29
Increased proportion of complement-receptor lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia. Blood (1972) 2.25
BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer (2008) 1.83
Reducing the occupational risk of infections for the surgeon: multicentric national survey on more than 15,000 surgical procedures. World J Surg (1997) 1.83
Bone marrow origin of complement-receptor lymphocytes. Eur J Immunol (1971) 1.80
Copper induction of laccase isoenzymes in the ligninolytic fungus Pleurotus ostreatus. Appl Environ Microbiol (2000) 1.69
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer (2003) 1.67
Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. Cancer Epidemiol Biomarkers Prev (1997) 1.66
Immune phagocytosis in murine malaria. J Exp Med (1979) 1.66
The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets (2005) 1.59
A novel white laccase from Pleurotus ostreatus. J Biol Chem (1997) 1.52
The induction of macrophage spreading by factor B of the properdin system. J Exp Med (1979) 1.50
The role of EGF-related peptides in tumor growth. Front Biosci (2001) 1.45
Complement receptors. Contemp Top Mol Immunol (1977) 1.44
Concurrent nitroglycerin administration reduces the efficacy of recombinant tissue-type plasminogen activator in patients with acute anterior wall myocardial infarction. Am Heart J (1995) 1.39
Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion. Evidence of volunteer blood donor cooperation. Transfusion (1985) 1.36
Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer (1995) 1.35
Autopsy findings in 111 cases of esophageal cancer. Cancer (1981) 1.34
Incidence, diagnosis, and treatment of enteric and colorectal fistulae in patients with Crohn's disease. Ann Surg (1993) 1.30
Regulation of macrophage migration by products of the complement system. Proc Natl Acad Sci U S A (1979) 1.29
C3 split products inhibit the binding of antigen-antibody-complement complexes to B lymphocytes. J Immunol (1973) 1.28
A population of lymphocytes bearing a membrane receptor antigen-antibody-complement complexes. II. Specific isolation. Cell Immunol (1971) 1.27
Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary's syndrome: morphologic and immunologic studies. Clin Immunol Immunopathol (1973) 1.27
Xanthogranulomatous cholecystitis. Histopathological study and classification. Pathol Res Pract (1990) 1.26
Monocyte receptors for fibronectin characterized by a monoclonal antibody that interferes with receptor activity. J Exp Med (1985) 1.25
Combined endoscopic treatment for cholelithiasis associated with choledocholithiasis. Surg Endosc (2005) 1.25
The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer (2000) 1.22
Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns (1989) 1.20
Interaction and release of soulble immune complexes from mouse B luymphocytes. Cell Immunol (1973) 1.14
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J Natl Cancer Inst (1996) 1.13
Fibronectin receptors of mononuclear phagocytes: binding characteristics and biochemical isolation. Exp Cell Res (1989) 1.11
Differentiation stimuli induce receptors for plasma fibronectin on the human myelomonocytic cell line HL-60. Blood (1984) 1.10
Prospective assessment of functional results after ileal J pouch-anal restorative proctocolectomy. Arch Surg (1993) 1.10
Plasma membrane polypeptides of resident and activated mouse peritoneal macrophages. Proc Natl Acad Sci U S A (1980) 1.10
Antibody-mediated cell cytotoxicity in a defined system: regulation by antigen, antibody, and complement. J Immunol (1976) 1.09
Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J Biol Chem (1997) 1.08
Expression of transforming growth factor alpha (TGF alpha) in breast cancer. Ann Oncol (1991) 1.08
Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2. Hybridoma (1992) 1.07
Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol (1995) 1.05
Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells. Exp Cell Res (2001) 1.05
Partial trisomy of the long arm of chromosome 1 due to a familial translocation t(1;10) (q32;q26). Hum Genet (1978) 1.04
Psychiatric comorbidity in patients with burning mouth syndrome. Psychosom Med (1998) 1.04
Anterior tension-free repair of recurrent inguinal hernia under local anesthesia: a 7-year experience in a teaching hospital. Ann Surg (2000) 1.04
Specific binding of the human monocytic cell line U937 to the alternatively spliced connecting segment (IIICS) of fibronectin. J Exp Med (1990) 1.04
A functional homologue of goosecoid in Drosophila. Development (1996) 1.03
Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells. Cancer Res (1999) 1.00
The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene (1997) 1.00
Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile. Clin Vaccine Immunol (2009) 0.99
Screening of blood donors for idiopathic CD4+ T-lymphocytopenia. Transfusion (1994) 0.99
Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice. J Pathol (2007) 0.98
Deferral of males who had sex with other males. Vox Sang (2011) 0.98
Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. Am J Pathol (1990) 0.98
Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic. Transfusion (2005) 0.98
[Carcinoid of the appendix. A case report]. Minerva Chir (2000) 0.98
RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells. Int J Cancer (2000) 0.97
Purification, characterization, and functional role of a novel extracellular protease from Pleurotus ostreatus. Appl Environ Microbiol (2001) 0.96
Activation of C3H/HeJ macrophages by endotoxin. J Immunol (1980) 0.96
Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry (1995) 0.95
Fibrin, fibronectin, and macrophages. Ann N Y Acad Sci (1983) 0.95
Gender-related clinical differences in obsessive-compulsive disorder. Eur Psychiatry (1999) 0.94
Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. Bioessays (1999) 0.93
A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression. J Affect Disord (2011) 0.93
Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway. Cell Growth Differ (1997) 0.92
Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial. Am J Obstet Gynecol (1994) 0.92
Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. J Immunol (1998) 0.91
High incidence of sperm sex chromosomes aneuploidies in two patients with Klinefelter's syndrome. J Clin Endocrinol Metab (1998) 0.91
High-efficiency red phosphorescent electroluminescence devices based on mixed p/n host matrices. Opt Lett (2010) 0.91
Further cases of lead poisoning from wine. Am J Ind Med (1984) 0.90
Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene (1994) 0.89
Transfusion-associated transmission of babesiosis in New York State. Transfusion (2000) 0.89
Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. Am J Physiol Regul Integr Comp Physiol (2000) 0.89
Surface characterization of silver-doped bioactive glass. Biomaterials (2005) 0.88
Surface modification of Ti-6Al-4V alloy for biomineralization and specific biological response: Part I, inorganic modification. J Mater Sci Mater Med (2011) 0.88
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients. Clin Microbiol Infect (2012) 0.88
Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes. Cancer (2001) 0.88
The DOse REsponse Multicentre International Collaborative Initiative (DO-RE-MI). Contrib Nephrol (2007) 0.87
The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene (1994) 0.87
Communication in the neonatal intensive care unit: a continuous challenge. J Matern Fetal Neonatal Med (2012) 0.87
Establishment and characterization of a primitive neuroectodermal tumor of bone continuous cell line (LAP-35). Int J Cell Cloning (1990) 0.87
Phorbol ester-induced differentiation of U937 cells enhances attachment to fibronectin and distinctly modulates the alpha 5 beta 1 and alpha 4 beta 1 fibronectin receptors. Exp Cell Res (1991) 0.86
Biobanks of blood from donors and recipients of blood products. Vox Sang (2008) 0.86
Cyclin D1 gene contains a cryptic promoter that is functional in human cancer cells. Genes Chromosomes Cancer (2001) 0.86
mRNA expression of transforming growth factor alpha in human breast carcinomas and its activity in effusions of breast cancer patients. J Natl Cancer Inst (1989) 0.85
Assessment of HIV-1 screening test sensitivities using serially diluted positive sera can give misleading results. Transfusion (1989) 0.85
Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues. Burns (1998) 0.85
Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin. J Nucl Med (1994) 0.85
Localization of macrophage agglutination factor activity to the gelatin-binding domain of fibronectin. J Immunol (1984) 0.85